# mo:re

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mo-re

- Industry: Pharmaceuticals
- Headquarters: Hamburg, Germany
- Website: www.more.science
- Total disclosed funding: $2.4M
- Latest round: Seed (Dec 9, 2024)
- Investors on record: 5

## About

mo:re is a technology company specializing in robotic solutions that automate medical research processes, enhancing efficiency and standardization in cell culture studies. Founded in 2023 in Hamburg, Germany, mo:re develops innovative research automation tools. The company recently raised EUR 2.3 million in Seed funding on December 9, 2024, to support its market entry and team expansion. The funding round was led by High-Tech Gründerfonds and included investors such as Gilson Inc., Innovationsstarter Fonds Hamburg, and Nidobirds Ventures GmbH. The company's founder, whose previous ventures are not noted, has focused on advancing laboratory automation technologies.The company specializes in a compact robotic and software platform designed to enhance the capabilities of medical research studies. Their primary offering includes an AI-assisted 3D cell culture robot, which automates cultivation processes to ensure cell survival and standardization throughout both short- and long-term research studies. This innovative device streamlines experimental planning by providing standardized protocols and adhering to industry best practices, thereby enhancing traceability and reproducibility essential for research publications and regulatory approvals. The platform caters to a diverse client base, primarily research laboratories, academic institutions, and pharmaceutical companies focusing on animal-free medical research.The company's revenue model centers around direct sales and possibly subscription services related to its robotic technologies and software solutions. Transactions typically occur between the firm and its clients, which include academic institutions and pharmaceutical companies that require efficient laboratory automation solutions. Clients may engage with the company to procure the flagship Mo:re Robot, which is instrumental in expediting research processes. The pricing structure is designed to accommodate varying client needs and project scales, with different packages available for single-unit purchases and potential subscription options for ongoing software support and updates. This structure allows clients to optimize their laboratory workflows while benefiting from seamless integration of the company's products into their existing research frameworks.In December 2024, mo:re raised EUR 2.3 million in Seed funding, valuing the company at EUR 7.22 million post-money. The funding will be utilized to establish a market presence and expand the team. The company plans to enhance its product offerings, focusing on the development of new versions of its robotic solutions targeted at research facilities globally. Specific regions for market expansion have not been detailed, but the goal is to penetrate advanced biomedical research markets by 2025.

## Funding rounds

- Seed, Dec 9, 2024, $2.4M — High-Tech Gruenderfonds, Innovationsstarter Fonds Hamburg, Nidobirds Ventures, Gilson Inc., Nedgex

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- Innovationsstarter Fonds Hamburg (https://capitalatlas.ai/funds/innovationsstarter-fonds-hamburg) — Seed
- Nidobirds Ventures (https://capitalatlas.ai/funds/nidobirds-ventures) — Seed
- Gilson Inc. — Seed
- Nedgex (https://capitalatlas.ai/funds/nedgex) — Seed